Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Estramustine Phosphate Capsules

Approval Number

国药准字HJ20170266

CompanyPfizer Italia S.R.L.

Registration Date

March 21, 2022

Previous Approval Numbers

H20170266

Drug Information

Generic Name

磷酸雌莫司汀胶囊

Trade Name

艾去适

Brand Name

艾去适

Dosage Form

胶囊剂

Strength

0.14g

Drug Type

化学药品

Registration Date

March 21, 2022

Expiry Date

March 20, 2027

Company Information

Applicant Company

Company NamePfizer Italia S.R.L.

Company Address

Via Isonzo, 71 - 04100 Latina, Italy

Manufacturing Company

Company NamePfizer Italia S.R.L.

Company Address

Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy